Donoghue Leslie, Nguyen Khanh T, Graham Caleb, Sethu Palaniappan
Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Micromachines (Basel). 2021 Jan 28;12(2):139. doi: 10.3390/mi12020139.
Tissue chips (TCs) and microphysiological systems (MPSs) that incorporate human cells are novel platforms to model disease and screen drugs and provide an alternative to traditional animal studies. This review highlights the basic definitions of TCs and MPSs, examines four major organs/tissues, identifies critical parameters for organization and function (tissue organization, blood flow, and physical stresses), reviews current microfluidic approaches to recreate tissues, and discusses current shortcomings and future directions for the development and application of these technologies. The organs emphasized are those involved in the metabolism or excretion of drugs (hepatic and renal systems) and organs sensitive to drug toxicity (cardiovascular system). This article examines the microfluidic/microfabrication approaches for each organ individually and identifies specific examples of TCs. This review will provide an excellent starting point for understanding, designing, and constructing novel TCs for possible integration within MPS.
包含人类细胞的组织芯片(TCs)和微生理系统(MPSs)是用于疾病建模和药物筛选的新型平台,为传统动物研究提供了替代方案。本综述重点介绍了TCs和MPSs的基本定义,研究了四个主要器官/组织,确定了组织和功能的关键参数(组织构建、血流和物理应力),回顾了当前用于重建组织的微流控方法,并讨论了这些技术开发和应用的当前不足及未来方向。所强调的器官是那些参与药物代谢或排泄的器官(肝脏和肾脏系统)以及对药物毒性敏感的器官(心血管系统)。本文分别研究了每个器官的微流控/微制造方法,并确定了TCs的具体实例。本综述将为理解、设计和构建新型TCs以可能整合到MPS中提供一个很好的起点。